SCHEMBL4126818

SCHEMBL4126818

O=C1C(=Cc2ccc(O)c(O)c2)SC(=S)N1Cc1ccc2c(c1)OCO2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.67
▸ KMT2A Q03164 8/20 0.67
▸ POLB P06746 5/20 0.67
▸ GAA P10253 2/20 0.67
▸ CASP3 P42574 2/20 0.67
▸ SENP8 Q96LD8 2/20 0.67
▸ SENP7 Q9BQF6 2/20 0.67
▸ SENP6 Q9GZR1 2/20 0.67
▸ HSP90AA1 P07900 1/20 0.67
▸ MAPK1 P28482 5/20 0.62
▸ HSD17B3 P37058 1/20 0.54
▸ ATM Q13315 2/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ CTDSP1 Q9GZU7 1/20 0.53
▸ PTPN7 P35236 2/20 0.53
▸ PTPN12 Q05209 2/20 0.53
▸ GPR35 Q9HC97 2/20 0.53
▸ PTPN22 Q9Y2R2 2/20 0.53
▸ MAPT P10636 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4126817 1.00 MEN1 (0.67) MEN1KMT2APOLBGAACASP3
SCHEMBL4138638 0.92 MAPK1 (0.72) MEN1KMT2APOLBGAACASP3
SCHEMBL4138637 0.92 MAPK1 (0.72) MEN1KMT2APOLBGAACASP3
SCHEMBL4133300 0.89 MEN1 (0.70) MEN1KMT2APOLBGAACASP3
SCHEMBL4128122 0.89 MEN1 (0.70) MEN1KMT2APOLBGAACASP3
SCHEMBL4133297 0.89 MEN1 (0.70) MEN1KMT2APOLBGAACASP3
SCHEMBL4128120 0.89 MEN1 (0.70) MEN1KMT2APOLBGAACASP3
SCHEMBL4132935 0.88 MEN1 (0.61) MEN1KMT2APOLBGAACASP3
SCHEMBL4132938 0.88 MEN1 (0.61) MEN1KMT2APOLBGAACASP3
SCHEMBL4142257 0.87 MEN1 (0.71) MEN1KMT2APOLBGAACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
WO-2008043733-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS LEK PHARMACEUTICAL D.D. (SI) 2008-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MEN1 2336/4885KMT2A 1459/4885POLB 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback